1Molica S, Vitelli G, Levato D, et al. Clinicoprognostic implications of increased serum level of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia . Br J Cancer, 2002; 86: 31- 35
2Niitsu N, Okamato M, Nakamine H, et al. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin'lymphoma. Eur J Haematol, 2002; 68: 91 - 10
3Dias S, Choy M, Alitalo K, et al. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4(VEGFR-3) mediates leukemic cell proliferation , survival , and resistance to chemotherapy.Blood, 2002; 99:2179-2184
4Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascnlar endothelial growth factor and its receptor in hematopoietic malignancies. Cancer Res, 1999; 59:728-733
5Aguayo A,Estey E,Kantarjian H,et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood, 1999; 94: 3717- 3721
6Verstovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of cellular vascular endothelial growth factor expressionor in chronic phase chronic myeloid leukemia. Blood, 2002; 99:2265- 2267
7Dias S, Shmelkov SV, Lam G, et al. VEGF(165) promotes survival of leukemic cells by Hsp9 mediated induction of Bcl-2 expression and apoptosis inhibition. Blood, 2002 ;99: 2532- 2540
8King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem, 1995; 58: 175- 180
9King KL,Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol, 1998; 60:601 - 617
10Bellamy WT, Richter L, Frutiger Y, et al. Expression of VEGF and its receptor in hematopoietic malignancies[J]. Cancer Res, 1999, 59(3):728-733.
